Ensysce Biosciences, Inc. (ENSC) Q4 2024 Annual Earnings
ENSC·Reported March 10, 2025·Before market open
Ensysce Biosciences, Inc. reported Q4 2024 revenue of $1.3M, beat analyst consensus of $245.0K by $1.1M. Diluted EPS came in at $-2.90, missed the $-2.74 consensus by $0.16.
Revenue
$1.3Mbeat by $1.1M
Consensus: $245.0KDiluted EPS
$-2.90missed by $0.16
Consensus: $-2.74
Financial Snapshot
Trailing eight quarters through Q4 2024
Q4 2024 Earnings FAQ
Common questions about Ensysce Biosciences, Inc.'s Q4 2024 earnings report.
Ensysce Biosciences, Inc. (ENSC) reported Q4 2024 earnings on March 10, 2025 before market open.
Ensysce Biosciences, Inc. reported revenue of $1.3M and diluted EPS of $-2.90 for Q4 2024.
Revenue beat the consensus estimate of $245.0K by $1.1M. EPS missed the consensus estimate of $-2.74 by $0.16.
You can read the 10-K periodic report (0001493152-25-009703) directly on SEC EDGAR. The filing index links above go to sec.gov.